Publication | Closed Access

Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model

Breast OncologyOncologyMedicineBreast CancerPharmacotherapyNon-steroidal Antioestrogen MonohydroxytamoxifenAnti-cancer AgentAntitumour ActivityPharmacologyRadiation OncologyCancer ResearchEndocrine-related Cancer